Published: April 9, 2025 By Avery Bleichfeld When Ken Reeves was diagnosed with prostate cancer in 2019, it came with all the stress and concern that a cancer diagnosis carries. But, beyond the struggles of dealing with the diagnosis, he also faced frustrations with the care he was receiving — his concern…
Groups fight stigma around prostate cancer prevention, care among Springfield men Updated: Mar. 09, 2025, 5:03 a.m. | Published: Mar. 09, 2025, 5:03 a.m. By Dave Canton dcanton@repub.com SPRINGFIELD – Archie Emanuel, Jr., a Vietnam-era veteran, remembered the day he received his diagnosis. “I had all the blood work and the urologist…
[su_youtube url=”https://www.youtube.com/watch?v=hv8fgetucDo&feature=youtu.be” mute=”yes”] Learn More
Prostate Cancer Awareness Forum on BCA-TV More
Panel on Women in Urology
NAACP Prostate Cancer Awareness 3-14-19
August 2, 2016 Vincent J. Gnanapragasam [ultimate_spacer height=”32″] Abstract Introduction Over 80% of the nearly 1 million men diagnosed with prostate cancer annually worldwide present with localised or locally advanced non-metastatic disease. Risk stratification is the cornerstone for clinical decision making and treatment selection for these men. The most widely applied stratification systems use presenting…
PUBLIC RELEASE: 28-JUL-2016 Full Article Prostate cancer patients have been offered hope after scientists at Newcastle University, UK, have identified a new group of molecules that could be targeted to slow tumor growth. Experts used an advanced screening technique which found hundreds of genes were affected by the male hormone testosterone. It is believed this could…
PUBLIC RELEASE: 28-JUL-2016 [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Study reveals protein’s ability to block expression of metastasis-linked genes UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER PUBLIC RELEASE: 28-JUL-2016 Although it reads like European license plate number, a protein known as ZMYND8 has demonstrated its ability to block metastasis-linked genes in prostate cancer, according to a study at…
New York, NY, July 25, 2016 Researchers found no significant differences in health related quality of life between patients with low risk prostate cancer on active surveillance and men without the disease over 3 years of followup, according to new study in the Journal of Urology ELSEVIER HEALTH SCIENCES [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] Active surveillance…